The COVID-19 pandemic required laboratories to operate at a record scale in a reduced timelines creating more potential opportunities for accidental template contamination. Three basic recommendations ...
Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...
The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...
In this webinar, Victoria Quiett of Thermo Fisher Scientific will dive into a comprehensive look at key components of running Pharmacogenomics (PGx) in your lab. The webinar will discuss the ...
Daniel Blanchard (left) is a molecular biologist and geneticist by training who, before joining Thermo Fisher Scientific (MA, USA), spent many years in academia, working mainly on RNA biology, RNAi ...
CARLSBAD, Calif.--(BUSINESS WIRE)--To help molecular diagnostic manufacturers and clinical testing laboratories adapt to higher-standard In Vitro Diagnostic Requirements (IVDR) now in effect in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results